Sort   by:  
 Page size 
UnknownDoes the Type of Extracorporeal Shock Therapy Influence Treatment Effectiveness in Lateral Epicondylitis? A Systematic Review and Meta-analysis.
Not available
S-EPMC7491893 | biostudies-literature
TranscriptomicsPredective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer
This study aimed to identify the genetic signatures associated with disease prognosis in bladder cancer. We used 165 primary bladder cancer samples, 23 recurrent non-muscle invasive tumor tissues, 58 normal looking bladder mucosae surrounding cancer and 10 normal bladder mucosae for microarray analy...
ORGANISM(S): Homo sapiens 
2010-05-28 | E-GEOD-13507 | biostudies-arrayexpress
UnknownData on molecular characterization and expression of the C-reactive protein (CRP) gene from rock bream, Oplegnathus fasciatus.
Not available
S-EPMC6811888 | biostudies-literature
UnknownPhase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.
Not available
S-EPMC7019768 | biostudies-literature
UnknownBand-selective gap opening by a C 4-symmetric order in a proximity-coupled heterostructure Sr2VO3FeAs.
Not available
S-EPMC8617490 | biostudies-literature
UnknownPromoter polymorphism (-590, T/C) of interleukin 4 (IL4) gene is associated with rheumatoid arthritis: An updated meta-analysis.
Not available
S-EPMC5272927 | biostudies-literature
UnknownBortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
Not available
S-EPMC3434979 | biostudies-literature
UnknownEffects of Obesity and Family History of Diabetes on the Association of CETP rs6499861 with HDL-C Level in Korean Populations.
Not available
S-EPMC7379118 | biostudies-literature
UnknownMolecular cloning and characterisation of the rock bream, Oplegnathus fasciatus, Fas (CD95/APO-1), and its expression analysis in response to bacterial or viral infection.
Not available
S-EPMC3787727 | biostudies-literature
UnknownCombined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor.
Not available
S-EPMC4226803 | biostudies-literature
Sort   by:  
 Page size